Cargando…
Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
Between January 1991 and December 1992 a phase I trial of superficial photodynamic therapy (PDT) using topical application of 5-aminolaevulinic acid (ALA) was undertaken to treat Bowen's disease, superficial basal cell carcinomas (BCCs) and metastatic skin secondaries from breast (adenocarcinom...
Autores principales: | Cairnduff, F., Stringer, M. R., Hudson, E. J., Ash, D. V., Brown, S. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968847/ https://www.ncbi.nlm.nih.gov/pubmed/8123497 |
Ejemplares similares
-
Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man.
por: Gilson, D., et al.
Publicado: (1988) -
5-aminolaevulinic acid-based photodynamic therapy inhibits ultraviolet B-induced skin photodamage
por: Hua, Hui, et al.
Publicado: (2019) -
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993) -
Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation
por: Wyld, L, et al.
Publicado: (2002) -
5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts
por: Wang, Xiaochuan, et al.
Publicado: (2017)